# LLM call: summary

- Turn: 12
- Sequence: 7
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 817
- Completion tokens: 323
- Total tokens: 1253
- Cost (USD): 0.000147

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-1517: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
Through 2028-2031 defensive posture was tested by spring sweep: model-written malware via update channel locked municipal portals in three countries, forced hospitals to offline stack for weeks; by autumn H2 2031 telemetry via pooled hub and EU-only node plus completed joint cyber accession (playbooks, signatures, liaisons) delivered containment — cleaner networks but degraded services, late payments, paper slips, uncredited by voters.

Washington chip/model controls stayed tight — volumes capped, servicing hardened, Dutch maker compliant; gigafactory shells empty; no EU relief request.

Office AI hiring collapse sharpened: law, accounting, software, customer centres and back-offices stopped replacing entry posts, graduate queues with no openings. Brussels top-up turned placement scheme into first-job guarantee — 6-12 month wage-subsidised posts in town halls, hospitals on offline systems, firms on accredited EU hosting; DG EMPL reprogrammed funds, emergency advances to arrears first. Uneven: funded cities hired and queues shortened where clean; elsewhere councils traded data-centre continuity for hiring quotas, two blockaded sites shut weeks, permit-halt debate dragged, student/job and siting protests merged. Criticised as posts not careers, training burden unfunded. Ministers claimed hookup prevented worse and guarantee showed Brussels could pay; oppositions cited borrowed protection and subsidised hiring. Trust thinned further as essentials degraded rather than stopped.

CURRENT NARRATIVE:
### A cure arrives, through someone else's machines
The news that dominated spring was not from Brussels. Laboratories abroad announced tailored therapies — oncology protocols tuned to a patient's own tumour, rare-disease treatments designed in weeks — moving into ordinary clinical use. For families who had waited years, it was the first unambiguously good technology story in memory. For health ministries, it was a procurement panic.

The catch was quickly understood in hospitals: personalization ran on frontier models hosted outside Europe, on compute Europe did not control, under access tiers that rationed clinical queries. Doctors spoke of miraculous drafts arriving with usage meters attached.

### The guarantee holds, barely
The first-job guarantee kept paying. DG EMPL advances reached arrears municipalities, and clean-network cities hired cohorts into town halls and offline hospital administration. Supervisors got a small training allowance that quieted the worst complaints, and two blockaded data-centre sites traded limited continuity for binding local hiring quotas — enough to reopen one, keep the other in negotiation, and prevent the student and siting protests merging further.

It did not create careers. Queues shortened where systems were clean and barely moved elsewhere. But with entry hiring frozen across law, accounting, software and back-offices, even subsidised posts were defended fiercely by mayors.

### Cure delivery, promised as European
Brussels tried to make the therapies arrive as European healthcare. Health ministers mandated pilot oncology and rare-disease centres in clean-network cities, staffed in part by guarantee cohorts, with diagnostics and cold-chain bought through joint procurement and any model-dependent personalization kept on accredited European hosting and the EU-only network node.

In practice, preparation outran delivery. Protocols cleared, procurement started, pilots were named — but the first patients treated under the new pathways were few, and clinicians still routed complex cases through foreign systems to avoid delay. Voters saw headlines about cures and waiting lists for access in the same week. Relief mixed with a fresh lesson in dependence, and trust rose only slightly from a floor.

Essential services degraded rather than stopped, but the budget for holding both jobs and cures thinned to almost nothing.
```

## Raw response

```
Through 2028-2031 defensive posture was tested by spring sweep: malware via update channel locked portals in three countries, forced hospitals offline for weeks; by autumn H2 2031 pooled hub + EU-only node and joint cyber accession delivered containment — cleaner networks but degraded services, late payments, paper slips.

Washington chip/model controls stayed tight, gigafactory shells empty; no EU relief request.

Office AI hiring collapse froze entry posts in law, accounting, software, back-offices. Brussels top-up became first-job guarantee — subsidised posts in town halls, offline hospitals, firms on EU hosting; DG EMPL advances to arrears first. Uneven: clean cities hired, others traded data-centre continuity for quotas, blockades, merged protests. Criticised as posts not careers.

Spring 2032: foreign labs brought tumour-tuned oncology and rapid rare-disease therapies into clinical use via frontier models on non-EU compute with rationed access — procurement panic for health ministries. Guarantee held barely with training allowance and quota deals reopening one blockaded site; queues shortened only where clean. Brussels promised European delivery via pilot oncology/rare-disease centres in clean cities, joint procurement, EU hosting/node — but protocols/procurement outran delivery, clinicians still routed complex cases abroad. Voters saw cure headlines alongside waiting lists; trust rose slightly from floor, budgets for holding jobs and cures nearly exhausted.
```
